DuPont de Nemours Inc. (DD)

71.60
NYSE : Process Industries
Prev Close 71.06
Day Low/High 70.82 / 71.94
52 Wk Low/High 63.28 / 100.54
Avg Volume 3.54M
Exchange NYSE
Shares Outstanding 745.48M
Market Cap 52.97B
EPS 5.00
P/E Ratio 20.47
Div & Yield 1.20 (4.17%)
Trending Tickers: NFLX, TSLA, TASR, DOW

Trending Tickers: NFLX, TSLA, TASR, DOW

Tesla shares rise after the company reports a record number of quarterly deliveries.

From The Street of Dreams

Citigroup raised DuPont to Buy from Neutral and increases the share price target to $76 from $72.

EU News Should Goose DuPont

I suspect DuPont shares will trade a bit better in the near term after news that a timetable has been established in the restart of the European Union review of its planned merger with Dow Chemical . DuPont remains my favorite large-capitalization l...

'Higher Value' Chemistry Key to Turnaround Says Chemours CEO

'Higher Value' Chemistry Key to Turnaround Says Chemours CEO

Chemours is up over 153% year-to-date and more than 50% since a short-seller targeted the chemical maker.

My Takeaways and Observations

I met with three companies this morning; alas, all uninteresting from a research standpoint. Fubar! Apple was a star. I am short and got shorter today. The momentum chasers who hated the shares at $103 now love them at $113 despite the technical res...

My Takeaways and Observations

Phew! One can't apply rational analysis to the daily price action any more. As I wrote yesterday and this morning, the only certainty to me is the likely increased volatility ahead. At least based on the last two days, I apparently was a master of u...

Breaking Bad (Part Deux)

"As I do every morning, please begin your day asking the following key questions: In a paperless and cloudy world, are investors and citizens as safe as the markets assume we are? In a flat, networked and interconnected world, is it even possible fo...

Jim Cramer: EU May Not Approve the Dow-Dupont Merger

Jim Cramer: EU May Not Approve the Dow-Dupont Merger

Jim Cramer is skeptical the Dow Chemical merger with DuPont will be approved by regulators.

Morning Movers: AAPL, DOW, DD, RH, MFRM

Morning Movers: AAPL, DOW, DD, RH, MFRM

Dow Chemical and Dupont's proposed merger could face regulatory hurdles in Europe as regulators paused their review of the deal due to insufficient information provided by the companies.

Thursday's Takeaways

A lot of good stuff and volume of ideas (I hope you agree!) in my Diary and elsewhere on our site today. I took a few bites of Apple in my opening missive. (My view has been consistent - sell/short Apple, don't own Apple). The Good, The Bad and The ...

Monsanto Wants Bayer Bid Security, but That Won't Stop a Regulatory Kibosh

Monsanto Wants Bayer Bid Security, but That Won't Stop a Regulatory Kibosh

Bayer increases its latest offering to entice Monsanto, as regulators look closely at agribusiness mergers.

Dow and DuPont Deal Could Be in Trouble

Dow and DuPont Deal Could Be in Trouble

The proposed merger between Dow Chemical and DuPont could be in jeopardy.

Dow Deal Could Be in Health-Care Hotseat

Dow Deal Could Be in Health-Care Hotseat

But even if Dow/DuPont merger fails, Dow is in good stead.

Jim Cramer: I Think the EU Will Block Monsanto-Bayer Deal

Jim Cramer: I Think the EU Will Block Monsanto-Bayer Deal

Jim Cramer says he doesn't think the Monsanto and Bayer merger will be approved by regulators.

My Takeaways and Observations

If today was a song it would be Cream's "Strange Brew."  As examples: Oil is lower yet energy stocks -- including my shorts Exxon Mobil and Schlumberger -- are higher. Treasury yields are lower and the yield curve flattens, yet banks and financials ...

Strange Brew

"She's some kind of demon messin' in the flue. If you don't watch out it'll stick to you, To you. What kind of fool are you? Strange brew -- killin' what's inside of you." -- Cream, Strange Brew DuPont and Radian are hitting multi-month highs as the...

Cramer: The Answer to This Market: Part 2

Cramer: The Answer to This Market: Part 2

I learned a long time ago, don’t outthink it.

Today's Good, Bad and Ugly

If you work for a living, why do you kill yourself working? --Tuco the Ugly, "The Good, The Bad and The Ugly" Speaking of the subject du jour -- drugs -- the market appears to be on Quaaludes.  Yet another day of modest price changes, with a few exc...

Today's Takeaways and Observations

Another snore fest today. The widening disconnect between stock prices and the real economy.  Mark Hanson on the disappointing housing data today. Thus far, Apple short (calls) --my Trade of the Week -- are doing well. At $10 I added J.C. Penney to ...

Today's Takeaways and Observations

Sell in September or get dismembered?  Another snore-fest as the invisible hand (and dirty float) of liquidity buoys global equities.  Again the markets are distorted -- from Jim Grant. Don't count on its continuation; ultimately, natural price disc...

DuPont Looks DuLovely

DuPont has finally breached $70 to the upside (albeit only briefly). I originally put DuPont on my "Best Long Ideas" list in Jan. 26 at $52.87, and I've been adding to this position over the past few months whenever the stock showed any weakness. An...

Don't Be a Revenge Trader

Don't Be a Revenge Trader

Plus 4 stocks that are rocking the charts.

Today's Takeaways and Observations

"May God bless and keep you always. May your wishes all come true. May you always do for others And let others do for you. May you build a ladder to the stars And climb on every rung. May you stay forever young. Forever young. Forever young. May you...

My Takeaways and Observations

Bloomberg Radio, listen!  Bloomberg TV, watch!   I have a crush on Twitter .  Why the rally in retail may not be justified. Parts one and two and three. I am a buyer of Macy's down 10% (or so) from here.  I initiated a small J.C. Penney long.  I add...

My Price Points for Adding to My Longs

Here are the price points where I'll be adding to my various long positions: DuPont : $65 or lower. Hartford Financial : $40 or lower. Oaktree Capital : $44.50 or lower. Radian : $12.50 or lower. Twitter : $17.25 or lower.

Today's Good, Bad and Ugly

"Two hundred thousand dollars is a lot of money. We're gonna have to earn it." --Blondie, "The Good, The Bad and The Ugly" Let's look at the good, the bad and the ugly (my new daily feature) so far in today's trading session: The Good Biotech is dan...

My Takeaways and Observations

I had a hectic day and a hectic week! All over the place, literally. On investment process, I'm keeping it real.  Beware of taking heads who have high conviction in their commodities price forecasts. A breakdown in the price of crude oil, Equity Res...

Midday Report: NetSuite Soars on Oracle Deal; Ford, Boeing Slide

Midday Report: NetSuite Soars on Oracle Deal; Ford, Boeing Slide

Another heavy day on the earnings front kept investors busy.

Jim Cramer: Dow-Dupont Merger Approval Still in Question

Jim Cramer: Dow-Dupont Merger Approval Still in Question

It's unclear if the Dow Chemical and Dupont merger will take place, according to TheStreet's Jim Cramer.

My Takeaways and Observations

Another strange day, with old relationships -- stocks (especially European bank stocks), bonds, precious metals, currencies and so forth -- breaking down and inconsequential in intraday or full-day action. To be honest, it's as if there is a "higher...